Live news related to ARGENX SE stock (NL0010832176): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on ARGENX SE mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €856,20 on Euronext Paris, down 1,34% at the last update. This page lists the articles published on ARGENX SE stock to track the share price, company announcements and any item likely to influence market perception.
The immunology group listed on Euronext and Nasdaq announced that members of its management team will speak at two financial events organized in the U…
The Dutch immunology group touches a new absolute peak during the session, surpassing the previous record established two days earlier. This spike occ…
The Dutch-based group has finalized the acquisition of the American company at a price of 77 dollars per share. The transaction integrates FB102, an a…
Argenx announced on August 17, 2026 positive primary results for its ALKIVIA phase 3 trial, which evaluated Vyvgart Hytrulo (efgartigimod) in adults w…
The immunology group has initiated the acquisition procedure for Forte Biosciences shares at a price of $77 per share, with a deadline set for August …
Argenx released its significantly improved results for the first half of the year on July 23, 2026. Operating revenues reached $2.85 billion, up from …
The Belgian immunology group's stock reaches a new all-time high during the session and continues its upward trajectory that began in the spring. Brea…
Argenx, an immunology specialist, is hosting a webinar today dedicated to its research and development in autoimmune myositis. The event brings togeth…
On Wednesday, Argenx will present long-term efficacy data for its immunosuppressant efgartigimod in two rheumatic autoimmune diseases, myositis and Sj…
Argenx announced on Thursday the organization of a webinar dedicated to its research and development in myositis, an autoimmune rheumatic disease. Thi…
